Measuring and Validating a General Cancer Predisposition Perception Scale: An Adaptation of the Revised-IPQ-Genetic Predisposition Scale

PLoS One. 2015 Nov 11;10(11):e0142620. doi: 10.1371/journal.pone.0142620. eCollection 2015.

Abstract

Background: Illness perceptions are linked to individual help-seeking and preventive behaviors. Previous illness perception studies have identified five dimensions of illness-related experience and behaviour. The Revised Illness Perception Questionnaire (IPQ-R) for genetic predisposition (IPQ-R-GP) was developed to measure illness perceptions in those genetically-predisposed to blood disease. We adapted the IPQ-R-GP to measure perceptions of generalized cancer predisposition. This paper describes the development and validation of the Cancer Predisposition Perception Scale (CPPS).

Methods: The draft CPPS scale was first administered to 167 well Hepatitis B carriers and 123 other healthy individuals and the factor structure was examined using Exploratory Factor Analysis. Then the factor structure was confirmed in a second sample comprising 148 healthy controls, 150 smokers and 152 passive smokers using Confirmatory Factor Analysis (CFA).

Results: Six-factors comprising 26 items provided optimal fit by eigen and scree-plot methods, accounting for 58.9% of the total variance. CFA indicated good fit of the six-factor model after further excluding three items. The six factors, Emotional representation (5 items), Illness coherence (4 items), Treatment control (3 items), Consequences (5 items), Internal locus of control (2 items) and External locus of control (4 items) demonstrated adequate-to-good subscale internal consistency (Cronbach's α = 0.63-0.90). Divergent validity was suggested by low correlations with optimism, self-efficacy, and scales for measuring physical and psychological health symptoms.

Conclusion: The CPPS appears to be a valid measure of perceived predisposition to generic cancer risks and can be used to examine cancer-risk-related cognitions in individuals at higher and lower cancer risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / genetics
  • Discriminant Analysis
  • Female
  • Genetic Predisposition to Disease*
  • Hepatitis B Surface Antigens / blood
  • Humans
  • Interviews as Topic
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / genetics
  • Male
  • Middle Aged
  • Neoplasms / diagnosis*
  • Neoplasms / genetics
  • Program Evaluation
  • Smoking
  • Surveys and Questionnaires
  • Translating
  • Young Adult

Substances

  • Hepatitis B Surface Antigens

Grants and funding

This work was funded by a grant from the Hong Kong Government’s Research fund for Health and Health Service Research (grant no: 08090791), http://rfs2.fhb.gov.hk/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.